CPYPP

SKU: orb1298859

Description

CPYPP is a cell-permeable small molecule inhibitor that selectively targets the DHR-2 domain of DOCK2, blocking its Rac1-GEF activity with an IC50 of 22.8 µM. It also inhibits related DOCK family members DOCK180 and DOCK5. This compound is a valuable research tool for studying Rac1-mediated signaling in immune cell migration and cancer metastasis in both cellular and animal models.

Key Properties

• CAS Number: 310460-39-0
• MW: 324.76
• Purity: 99.85% (May vary between batches)
• Formula: C₁₈H₁₃ClN₂O₂
• SMILES: Clc1ccccc1\C=C\C=C1/C(=O)NN(C1=O)c1ccccc1
• Target: Others
• Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.16 mM);DMSO:23 mg/mL (70.82 mM)

Bioactivity

• Target IC50:
  GEF activity of DOCK2DHR-2 for Rac1:22.8 µM
• In Vitro:
  CPYPP as a small-molecule inhibitor of DOCK2. CPYPP bound to DOCK2 DHR-2 domain in a reversible manner and inhibited its catalytic activity in vitro. When lymphocytes were treated with CPYPP, both chemokine receptor- and antigen receptor-mediated Rac activation were blocked, resulting in marked reduction of chemotactic response and T cell activation. These results provide a rational of and a chemical scaffold for development of the DOCK2-targeting immunosuppressant.
  Read more...

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

DOCK9, DOCK180, DOCK2, DOCK2-Rac1, DOCK5, CPYPP, autoimmune, lymphocytes, Inhibitor, immunosuppressant, inhibit, migration, GEF, Rac1

Compound Identifiers

PubChem CID

2248186